Bioorganic & Medicinal Chemistry
Brief Name:
BIOORGAN MED CHEM
Impact factor:
3.3 (2023)
ISSN:
0968-0896
Open Access:
No
Publisher:
Elsevier Ltd
Publication Frequency:
Semimonthly
Article Processing Charge:
$3840
Publication Start Year:
1993
Annual Articles:
238
Self-citation Rate:
3%
Chinese Academy of Sciences SCI Journal Classification:
| Major category | Ｍinor category | TOP journal | Ｒeview journal |
|---|---|---|---|
Q3 MEDICAL |
BIOCHEMISTRY AND MOLECULAR BIOLOGY | No | No |
Subject Classification:
BIOCHEMISTRY & MOLECULAR BIOLOGY
CiteScore:
| CiteScore | SJR | SNIP | CiteScore ranking | ||||||
|---|---|---|---|---|---|---|---|---|---|
| 6.8 | 0.614 | 0.817 |
|
H-Index:
142
SCI Index Status:
Science Citation Index Expanded
Official Review Time:
Time to first decision: 4days
Review time: 52days
Submission to acceptance: 56days
Acceptance to publication: 6days
PubMed Central:
Submission Site:
Aims and Scope:
The Tetrahedron Journal for Research at the Interface of Chemistry and Biology
Bioorganic & Medicinal Chemistry publishes complete accounts of research of outstanding significance and timeliness on all aspects of molecular interactions at the interface of chemistry and biology, together with critical review articles. The journal publishes reports of experimental results in medicinal chemistry, chemical biology and drug discovery and design, emphasizing new and emerging advances and concepts in these fields. The aim of the journal is to promote a better understanding at the molecular level of life processes, and living organisms, as well as the interaction of these with chemical agents.
The Journal welcomes papers on:
the medicinal chemistry and associated biology (including target identification and validation) of established or new disease targets
the reporting of the discovery, design or optimization of potent new compounds or biological agents
the analysis and discussion of structure-activity relationships and pharmacological issues relevant to drug design and action using in vitro and in vivo models, including the use of computational techniques when closely linked to experimental data
the reporting of "first-in-class" new therapeutic compounds
the chemical biology or bioorganic/bioinorganic chemistry that significantly advances knowledge of a biological mechanism
methodological advances that are chemistry-based and which significantly impact on medicine or biology
the preparation and examination of biotherapeutics for the treatment of pathophysiological disease states
the development of materials for specific therapeutic targeting
All manuscripts will be rigorously peer-reviewed by independent experts following an initial assessment by the Editors. Please note that BMC is not suitable for straightforward reports of incremental advances. Above all the presentation of a rational basis and a sound underlying hypothesis for the work is of particular importance, whatever its exact field.
Bioorganic & Medicinal Chemistry publishes complete accounts of research of outstanding significance and timeliness on all aspects of molecular interactions at the interface of chemistry and biology, together with critical review articles. The journal publishes reports of experimental results in medicinal chemistry, chemical biology and drug discovery and design, emphasizing new and emerging advances and concepts in these fields. The aim of the journal is to promote a better understanding at the molecular level of life processes, and living organisms, as well as the interaction of these with chemical agents.
The Journal welcomes papers on:
the medicinal chemistry and associated biology (including target identification and validation) of established or new disease targets
the reporting of the discovery, design or optimization of potent new compounds or biological agents
the analysis and discussion of structure-activity relationships and pharmacological issues relevant to drug design and action using in vitro and in vivo models, including the use of computational techniques when closely linked to experimental data
the reporting of "first-in-class" new therapeutic compounds
the chemical biology or bioorganic/bioinorganic chemistry that significantly advances knowledge of a biological mechanism
methodological advances that are chemistry-based and which significantly impact on medicine or biology
the preparation and examination of biotherapeutics for the treatment of pathophysiological disease states
the development of materials for specific therapeutic targeting
All manuscripts will be rigorously peer-reviewed by independent experts following an initial assessment by the Editors. Please note that BMC is not suitable for straightforward reports of incremental advances. Above all the presentation of a rational basis and a sound underlying hypothesis for the work is of particular importance, whatever its exact field.
Submission Guidelines:
Types of Articles Accepted:
original research
Reviews
Perspectives
Symposia-in-Prin
Reviews
Perspectives
Symposia-in-Prin
Reference Citations Format:
Disclaimer:
This page displays information about journals or magazines for reference and study purposes only. It is not the official website of any journal or magazine and does not involve publishing matters. Users must verify any publishing-related inquiries directly with the publisher.
If there are any issues with the content displayed on this page, please contact us at: [email protected], and we will verify and address the matter diligently.
This page displays information about journals or magazines for reference and study purposes only. It is not the official website of any journal or magazine and does not involve publishing matters. Users must verify any publishing-related inquiries directly with the publisher.
If there are any issues with the content displayed on this page, please contact us at: [email protected], and we will verify and address the matter diligently.